Abstract: A method for preparing a formaldehyde-free phenolic plastic resin, includes a step of preparing a hardener via careful oxidation of a polyol and a step of reacting the hardener with phenolic compounds.

Abstract: The present invention relates to compound (I) wherein: means a pyridazine, a pyrimidine or a pyrazine group, R independently represent a hydrogen atom, a halogen atom or a group chosen among a CN group, a hydroxyl group, a COOR1 group, a (C1-C3)fluoroalkyl group, a (C1-C3)fluoroalkoxy group, a NO2 group, a NR1R2 group, a (C1-C4)alkoxy group, a phenoxy group and a (C1-C3)alkyl group, said alkyl being optionally mono-substituted by a hydroxyl group, n is 1, 2 or 3, n is 1 or 2, R is a hydrogen atom, a halogen atom or a group chosen among a (C1-C3)alkyl group, a hydroxyl group, a COOR1 group, a NO2 group, a NR1R2 group, a morpholinyl or a morpholino group, a N-methylpiperazinyl group, a (C1-C3)fluoroalkyl group, a (C1-C4)alkoxy group and a CN group, Z is N or C, Y is N or C, X is N or C, W is N or C, T is N or C, U is N or C, for use as an agent for preventing, inhibiting or treating cancer. Some of said compounds are new and also form part of the invention.

Abstract: A device for measuring the activity of a liquid in a complex medium and an associated method, the device comprising a sealed enclosure in which the complex medium is intended to be placed and means for maintaining this enclosure at a constant temperature T, characterized in that it comprises: a means (14) for modifying the total volume of the enclosure; a pressure sensor (22) for measuring the total pressure in the enclosure; and means (24) for calculating the activity of the liquid in the complex medium from the temperature T, from the total volume of the enclosure and from the total pressure in the enclosure.

Abstract: A peptide including the amino acids sequence X9CGYX13X14AX16X17X18MX20X21X22X23X24X25X26X27CPLCX32X33, a nucleic acid coding for the peptide, and/or a recombinant vector including the nucleic acid for the preparation of a drug intended for the treatment of cancer.

Abstract: The invention relates to a method for measuring the pressure and/or molar mass of a gas in a housing, the measure being carried out via an acoustic sensor, said acoustic sensor at least one transducer (5), an electric system (8) connected to the transducer (5) and a coupling layer (6) for coupling the transducer (5) to the housing (1), said method comprising the following steps: generating using the transducer (5) an excitation acoustic signal that vibrates the housing (1) and the gas (2) in a wide frequency band; detecting with the transducer (5) a response acoustic signal characteristic of the vibrations of the housing and the gas; analysing the response electric signals from the transducer (5) using the system (8); and deriving, essentially based on the gas (2) resonance frequencies, the speed of the acoustic waves in the gas, the molar mass of the gas and the pressure thereof. The invention also relates to an assembly for implementing the method.

Abstract: The invention relates to active material for the negative electrode of secondary rechargeable lithium batteries, wherein the active material is based on doped or undoped carbon-bearing lithium titanium ramsdellite oxide with general formula Li2Ti3O7 or Li2.28Ti3.43O8. The active material comprises a carbon substituted ramsdellite phase having a general formula Li2?4cCc—Ti3O7, with 0.1<c<0.5, and more than 0.1 mol % of spinel phase having a general formula Li1+xTi2?xO4 with 0<x<0.33.

Abstract: The invention relates to conjugates of products of interest and of compounds targeting the cation-independent mannose 6-phosphate receptor with a high affinity. The invention also relates to their applications, for instance in enzyme replacement therapies.

Abstract: Method for the preparation of a composite electrode and accumulator or battery including at least one composite electrode, the method includes a step of pouring a medium including at least one ionic liquid, a lithium, sodium or magnesium salt with at least one inorganic molecular precursor or a polymerizable monomer, the medium being in excess, and an in situ polycondensation or polymerization step.

Abstract: The invention relates to processes for coating a surface with a crosslinked polyelectrolytes multilayer film incorporating a protein, preferably a growth factor type protein. The invention also relates to crosslinked polyelectrolytes multilayer films obtained by this process, and a coated surface obtained therefrom.

Abstract: The present invention concerns a chimeric polypeptide comprising several polypeptide domains, which is capable of being secreted in association with membrane vesicles and in particular exosomes. The present invention also concerns a polypeptide constituted by one of said domains for the secretion of a peptide or polypeptide of interest in association with membrane vesicles and in particular exosomes. The invention also concerns the use of polypeptides of the invention and of polynucleotides coding for said polypeptides for the production of immunogenic compositions based on exosomes or based on DNA or for screening protein interactions.

Abstract: The invention relates to a process for the hydrolysis-polycondensation of a sterically hindered crosslinkable chromophore, characterized in that the hydrolysis-polycondensation is catalyzed with an acid released by a photoacid generator (PAG).

Abstract: The disclosure relates to a method for growing an element III nitride, wherein the growth is carried out on a substrate made of a material capable of maintaining the same crystalline structure from the element III nitride growth temperature to room temperature, the substrate being an M-V—O4 alloy, where M denotes a transition metal or a Group III element, and where V denotes N, P, S, or Sb, or an (Si-IV)O2 alloy, where IV denotes a Group IV element other than silicon. The disclosure also relates to the structures and components obtained after the implementation of the method.

Abstract: The present invention relates to a compound of one of the formulas I to XXI; a pharmaceutical composition comprising at least one such compound; and the use of at least one such compound in preparing a drug to treat, in a subject, a genetic disease resulting from at least one splicing anomaly.

Abstract: The invention concerns a process for preparing a block or comb copolymer comprising at least one hydrophilic portion and at least two hydrophobic portions, by anionic solvent-free polymerization of a prepolymer selected from a polyethylene glycol and a polyvinyl alcohol, and of a lactone or dilactone monomer. The process is carried out in the presence of an alkaline-earth metal hydride, in an inert atmosphere, and the polymerization step is not carried out under vacuum. The invention also concerns copolymers obtained by this process.

Abstract: The present invention is directed to a method for the in vitro preparation of cardiovascular progenitors cells from mammalian embryonic stem cells (ES cells) or mammalian embryonic-like state cells, preferably from primate, wherein said method comprises the use of the CD15 (SSEAI) marker as a positive cardiovascular progenitors differentiation marker. The present invention also claimed the use of a receptor tyrosine kinase inhibitor, particularly the SU5402 or SU11248 in association with the BMP2 for improving the efficiency of the desired differentiation. The present invention is also directed to the use of platelet lysate as foetal animal serum substitute in a culture medium intended to the proliferation or propagation of primate ES cells maintaining their pluripotency feature. Derived compositions or kits in relation with the claimed methods or product obtainable by the claimed methods form also part of the present invention.

Abstract: A process for the “in situ” manufacture, in a pressurized CO2 medium, of coated particles. The manufacturing process is characterized in that the steps of synthesising the particles and of coating these particles are coupled in such a way that the synthesised particles remain dispersed in a pressurized CO2 medium at least until the coating. The device comprises a reactor for synthesising particles in a pressurized CO2 medium; a means of injecting the coating material or precursor thereof into said reactor; a means of supplying said reactor with a pressurized CO2 medium; in which the means of injecting the coating material or precursor thereof is coupled to the synthesis reactor in such a way that the injection of the coating material or precursor thereof into said reactor does not destroy the dispersion of the particles, in a pressurized CO2 medium, in said reactor.